These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 28355889)
21. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization. Su Z; Shi Y; Xiao Y; Sun M; Ping Q; Zong L; Li S; Niu J; Huang A; You W; Chen Y; Chen X; Fei J; Tian J Int J Pharm; 2013 Apr; 447(1-2):281-92. PubMed ID: 23396258 [TBL] [Abstract][Full Text] [Related]
22. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice]. Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740 [TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416 [TBL] [Abstract][Full Text] [Related]
24. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Gao W; Xiang B; Meng TT; Liu F; Qi XR Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200 [TBL] [Abstract][Full Text] [Related]
26. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer. Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559 [No Abstract] [Full Text] [Related]
27. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
28. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. Safwat S; Ishak RAH; Hathout RM; Mortada ND Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784 [TBL] [Abstract][Full Text] [Related]
29. Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers? Du J; Li L Drug Deliv; 2016 Jun; 23(5):1799-809. PubMed ID: 26455787 [TBL] [Abstract][Full Text] [Related]
30. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity. Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908 [TBL] [Abstract][Full Text] [Related]
31. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy. Yang Y; Xie X; Yang Y; Zhang H; Mei X J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979 [TBL] [Abstract][Full Text] [Related]
32. A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro. Han CY; Yue LL; Tai LY; Zhou L; Li XY; Xing GH; Yang XG; Sun MS; Pan WS Int J Nanomedicine; 2013; 8():1541-9. PubMed ID: 23626467 [TBL] [Abstract][Full Text] [Related]
33. Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies. Negi LM; Talegaonkar S; Jaggi M; Verma AK; Verma R; Dobhal S; Kumar V Colloids Surf B Biointerfaces; 2014 Nov; 123():610-5. PubMed ID: 25454755 [TBL] [Abstract][Full Text] [Related]
34. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233 [TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563 [TBL] [Abstract][Full Text] [Related]
36. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Zhang S; Wang J; Pan J Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105 [TBL] [Abstract][Full Text] [Related]
37. Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo. Yuan X; Fei F; Sun H; Xiao C; Zhao X; Zhang Y; Zheng X Int J Nanomedicine; 2018; 13():2265-2274. PubMed ID: 29695905 [TBL] [Abstract][Full Text] [Related]
38. Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice. Zhang XY; Qiao H; Ni JM; Shi YB; Qiang Y Eur J Pharm Sci; 2013 Jun; 49(3):411-22. PubMed ID: 23624327 [TBL] [Abstract][Full Text] [Related]
39. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713 [TBL] [Abstract][Full Text] [Related]
40. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Liu D; Liu Z; Wang L; Zhang C; Zhang N Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]